Zobrazeno 1 - 10
of 10
pro vyhledávání: '"M V Podryadnova"'
Publikováno v:
Научно-практическая ревматология, Vol 50, Iss 3, Pp 117-119 (2012)
Externí odkaz:
https://doaj.org/article/9c703b1d536941bb88243b658944ef13
Publikováno v:
Современная ревматология, Vol 15, Iss 3, Pp 57-61 (2021)
Over the past decades, there has been an increase in the incidence of asymptomatic hyperuricemia (AHU), which includes an increased level (>360 μmol/L) of uric acid (UA) in the blood serum of patients with no clinical manifestations of gout. AHU is
Externí odkaz:
https://doaj.org/article/72898f84c32246a2adafd07412f26830
Publikováno v:
Современная ревматология, Vol 14, Iss 4, Pp 157-160 (2020)
If standard therapy with nonsteroidal anti-inflammatory drugs is ineffective, biological drugs are usually prescribed for patients with active ankylosing spondylitis. These medicines are purchased in Russia not under their trade names, but under thei
Externí odkaz:
https://doaj.org/article/171a39c171394f058b2e4c0a02af0da0
Autor:
Sh. F. Erdes, M. V. Podryadnova
Publikováno v:
Современная ревматология, Vol 10, Iss 1, Pp 63-66 (2016)
Ankylosing spondylitis (AS) is a chronic progressive disease resulting in disability. Affecting mainly young and able-bodied people, AS considerably reduces the manpower of society. To date, it may be stated on the basis of the available data, that l
Externí odkaz:
https://doaj.org/article/7f35b0dc859a44069d9257aab22b6618
Publikováno v:
Научно-практическая ревматология, Vol 53, Iss 1, Pp 101-106 (2015)
The paper presents a brief review of the proceedings of the 15th Mediterranean Rheumatology Congress that was held in Istanbul, Turkey, in August 2014. This congress unites the scientists and physicians of Mediterranean countries and focuses the atte
Externí odkaz:
https://doaj.org/article/21a8b6323f4842b4b8bbee65d02fe281
Publikováno v:
Современная ревматология, Vol 8, Iss 4, Pp 86-89 (2014)
Ankylosing spondylitis (AS) is a chronic systemic disease with predominant axial skeleton injury, peripheral articular and entheseal involvements, and extra-skeletal manifestations. 8–10 years elapse since the first manifestations of AC to its diag
Externí odkaz:
https://doaj.org/article/e733a55a46164597bc80fa01bb60ef7c
Publikováno v:
Научно-практическая ревматология, Vol 58, Iss 2, Pp 232-237 (2020)
At present, there is more and more evidence in rheumatology on the factors influencing the efficacy of biological agents (BAs), and there is no generally accepted algorithm for managing patients resistant to standard therapy. The paper describes thre
Publikováno v:
Научно-практическая ревматология, Vol 52, Iss 4, Pp 417-422 (2014)
Objective: to compare the clinical manifestations of coxitis with the data of HJ ultrasound study (USS) on inpatient samples. Subjects and methods . This cross-sectional study enrolled 220 AS patients meeting the modified 1984 New York criteria who h
Publikováno v:
Научно-практическая ревматология, Vol 52, Iss 2, Pp 187-191 (2014)
Objective. To study how the patients with ankylosing spondylitis (AS) follow recommendations for performing physi- cal exercises. Material and methods. To clarify the compliance of patients with AC to physical exercise, a special questionnaire was de
Publikováno v:
Научно-практическая ревматология, Vol 52, Iss 5, Pp 513-519 (2014)
Objective: to study how clinical characteristics of ankylosing spondylitis (AS) affect working efficiency.Subjects and methods. Authors examined 220 patients with AS (162 males and 58 females). Mean age was 35.1±9.5 years, mean age of the disease ma
Externí odkaz:
https://doaj.org/article/b52cfe40a72545738a12f29cfbebb5d8